These three beaten-down cancer stocks could prove to be amazing value plays.
News & Analysis: Agenus
AGEN earnings call for the period ending June 30, 2019.
AGEN earnings call for the period ending March 31, 2019.
Surprise! This retailer and lesser-known biotechnology company could be potential multibaggers.
AGEN earnings call for the period ending December 31, 2018.
These biopharmaceutical startups have been losing their investors' money for decades.
Agenus' stock crushed it last month. Here's why.
Eli Lilly's acquisition of Loxo Oncology lit a fire underneath the cancer immunotherapy company today.
The Super Bowl of biotech kicked off early for these companies.
Biotech was a popular sector today. Find out why.